R.E. Aarnoutse

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis

R.E. Aarnoutse, Gibson Kibiki, Klaus Reither et al. · Antimicrobial Agents and Chemotherapy · 2017 · 93 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography

C.P.W.G.M. Verwey-van Wissen, R.E. Aarnoutse, David M. Burger · Journal of Chromatography B · 2004 · 90 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers

R.E. Aarnoutse, Jan Kleinnijenhuis, Peter J. Koopmans et al. · Clinical Pharmacology & Therapeutics · 2005 · 60 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Optimising pyrazinamide for the treatment of tuberculosis

Nan Zhang, Radojka M. Savić, Martin J. Boeree et al. · European Respiratory Journal · 2021 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Determination of Emtricitabine in Human Plasma using HPLC with Fluorometric Detection

J. A. H. Droste, R.E. Aarnoutse, D.M. Burger · Journal of Liquid Chromatography & Related Technologies · 2007 · 32 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17